Minn. R. agency 144, ch. 4770, pt. 4770.1850
Current through Register Vol. 49, No. 19, November 4, 2024
Part 4770.1850 - RECALL PROCEDURESA. Each manufacturer must establish a procedure for recalling medical cannabis that has a reasonable probability of causing an unexpected or harmful response in a patient population, despite appropriate use, that outweighs the potential benefit of the medication. This procedure must include:(1) factors that make a recall necessary;(2) manufacturer's personnel who are responsible for overseeing the recall; and(3) how to notify affected parties of a recall.B. The commissioner may order a manufacturer to undertake a recall of a dried raw cannabis finished good. The commissioner's order must be based on a reasonable suspicion that the finished good presents a risk of causing a serious adverse incident. The commissioner must order the recall of a dried raw cannabis finished good if testing under part 4770.3035 indicates the presence of residues from a crop input prohibited under part 4770.1700 are present in the finished good. A manufacturer must comply and cooperate with any recalls ordered by the commissioner.Minn. R. agency 144, ch. 4770, pt. 4770.1850